Hundreds of millions of people worldwide await treatments for rare diseases.

For patients with lung cancer, biomarker testing may be an option.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.

Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.

A diminutive protein prompts a closer look at DNA dark matter.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

Meet a Senior Medical Director at Novartis who is part of our new “Women in Science” series